Report cover image

Bioconjugation Market Growth, Size, Trends Analysis - By Product & Services, By Technique, By Biomolecule Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Sep 06, 2025
Length 242 Pages
SKU # SPER20519986

Description

Bioconjugation Market Introduction and Overview

According to SPER Market Research, ‘Global Bioconjugation Market Size- By Product & Services, By Technique, By Biomolecule Type, By Application, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Bioconjugation Market is predicted to reach 14.81 billion by 2034 with a CAGR of 9.73%.

Bioconjugation refers to the chemical or biological method of attaching two molecules, typically a biomolecule like an antibody, protein, or peptide, to another molecule such as a drug, fluorophore, or polymer, creating a functional unit. This process is crucial for targeted drug delivery, diagnostics, and molecular imaging, offering enhanced targeting and improved efficacy. Examples of bioconjugation include antibody–drug conjugates (ADCs), biosensors, and molecular imaging agents.

RESTRAINTS: A significant challenge facing the global bioconjugation market is the high expenses and complexities associated with the bioconjugation processes. These operations frequently necessitate sophisticated technologies, specialized reagents, and meticulous control over reaction conditions, which substantially elevate production costs. Furthermore, the requirement for site-specific conjugation to maintain biological activity adds to the intricacy.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Product & Services, By Technique, By Biomolecule Type, By Application, By End User

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Thermo Fisher Scientific, Danaher, Lonza Group, Merck KGaA (MilliporeSigma), Sartorius AG, Abbvie, Inc, Agilent Technologies, Inc, Bio-rad Laboratories, Inc, Catalent, Inc, BD.

Global Bioconjugation Market Segmentation:

By Product & Services: Based on the Product & Services, Global Bioconjugation Market is segmented as; Consumables, Instruments, Services.

By Biomolecule Type: Based on the Biomolecule Type, Global Bioconjugation Market is segmented as; Antibodies, Proteins, Peptides, Oligonucleotides, Other Biomolecules.

By Technique: Based on the Technique, Global Bioconjugation Market is segmented as; Chemical Conjugation, Enzyme-Mediated Conjugation, Click Chemistry, Photoreactive Crosslinking, Other Techniques.

By Application: Based on the Application, Global Bioconjugation Market is segmented as; Therapeutics, Research & Development, Diagnostics.

By End User: Based on End User, Global Bioconjugation Market is segmented as; Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, Hospitals, Clinical & Diagnostic Laboratories.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

242 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Bioconjugation Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bioconjugation Market
7. Global Bioconjugation Market, By Product & Services (USD Million) 2021-2034
7.1. Consumables
7.1.1. Reagents & Kits
7.1.2. Labels
7.2. Instruments
7.2.1. Chromatography Systems
7.2.2. Spectroscopy Instruments
7.2.3. Mass Spectrometers
7.2.4. Flow Cytometers
7.2.5. Electrophoresis Equipment
7.2.6. Filtration Systems
7.2.7. Mixers & Shakers
7.2.8. Incubators
7.2.9. Other Instruments
7.3. Service
7.3.1. Custom Synthesis & Conjugation Services
7.3.2. Analytical & Characterization Services
7.3.3. Scale-up & Manufacturing Services
7.3.4. Other Services
8. Global Bioconjugation Market, By Biomolecule Type (USD Million) 2021-2034
8.1. Antibodies
8.2. Proteins
8.3. Peptides
8.4. Oligonucleotides
8.5. Other Biomolecules
9. Global Bioconjugation Market, By Technique (USD Million) 2021-2034
9.1. Chemical Conjugation
9.2. Enzyme-Mediated Conjugation
9.3. Click Chemistry
9.4. Photoreactive Crosslinking
9.5. Other Technique
10. Global Bioconjugation Market, By Application (USD Million) 2021-2034
10.1. Therapeutics
10.1.1. Antibody-drug Conjugates
10.1.2. Protein-drug Conjugates
10.1.3. Peptide-drug Conjugates
10.1.4. Other Therapeutic Applications
10.2. Research & Development
10.3. Diagnostics
11. Global Bioconjugation Market, By End User (USD Million) 2021-2034
11.1. Pharmaceutical & Biotechnology Companies
11.2. CROs & CMOs
11.3. Academic & Research Institutes
11.4. Hospitals, Clinical & Diagnostic Laboratories
12. Global Bioconjugation Market, (USD Million) 2021-2034
12.1. Global Bioconjugation Market Size and Market Share
13. Global Bioconjugation Market, By Region, (USD Million) 2021-2034
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. Thermo Fisher Scientific
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Danaher
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Lonza Group
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Merck KGaA (MilliporeSigma)
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. Sartorius AG
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Abbvie, Inc
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Agilent Technologies, Inc
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Bio-rad Laboratories, Inc
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Catalent, Inc
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. BD
15.10.1. Company details
15.10.2. Financial outlook
15.10.3 Product summary
15.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us